Generic cholesterol drug shows promise in early comparison

NCT ID NCT07170852

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested whether a generic bempedoic acid tablet works the same as the brand-name drug Nilemdo in 32 healthy adults. Participants took a single dose of each under fasting conditions, and researchers measured drug levels in the blood. The goal was to see if the generic is absorbed similarly, which could lead to a more affordable option for managing high cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bempedoic acid

What this could lead to

If successful, this could help bring a lower-cost generic version of bempedoic acid to market for managing high cholesterol.

What could go wrong

This is a small, early-phase study in healthy volunteers, not patients. It only checks if the generic is absorbed similarly, not if it actually lowers cholesterol or prevents heart problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypercholesterolemia hypercholesterolemia, familial, 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cliantha Research Limited

    Noida, 201301, India